Julie X. Dang

Array ( [id] => 16261462 [patent_doc_number] => 10752883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Generation of neural stem cells and motor neurons [patent_app_type] => utility [patent_app_number] => 15/794137 [patent_app_country] => US [patent_app_date] => 2017-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 28 [patent_no_of_words] => 26327 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15794137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15086385 [patent_doc_number] => 20190338003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => AP4 AND METHODS OF PROMOTING T CELL ACTIVATION [patent_app_type] => utility [patent_app_number] => 16/343951 [patent_app_country] => US [patent_app_date] => 2017-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17436 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18962876 [patent_doc_number] => 11896615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => Immunotherapy methods and compositions involving tryptophan metabolic pathway modulators [patent_app_type] => utility [patent_app_number] => 16/340085 [patent_app_country] => US [patent_app_date] => 2017-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 70 [patent_no_of_words] => 118211 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12176715 [patent_doc_number] => 20180035652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-08 [patent_title] => 'TRANSPLANT FISH PRODUCTION METHOD, TRANSPLANT FISH, HYBRID FISH SPECIES PRODUCTION METHOD, AND HYBRID FISH SPECIES' [patent_app_type] => utility [patent_app_number] => 15/714123 [patent_app_country] => US [patent_app_date] => 2017-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11021 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12125163 [patent_doc_number] => 20180008749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'Adhesion Preventing Material' [patent_app_type] => utility [patent_app_number] => 15/710507 [patent_app_country] => US [patent_app_date] => 2017-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5381 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15710507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12625002 [patent_doc_number] => 20180100164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-12 [patent_title] => MODIFIED SEROTYPE 28 ADENOVIRAL VECTORS [patent_app_type] => utility [patent_app_number] => 15/700279 [patent_app_country] => US [patent_app_date] => 2017-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9552 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15700279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14749285 [patent_doc_number] => 20190257816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => DIFFERENTIAL BH3 MITOCHONDRIAL PROFILING [patent_app_type] => utility [patent_app_number] => 15/698281 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18051746 [patent_doc_number] => 11525119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-13 [patent_title] => Immune cells derived from induced pluripotent stem cell [patent_app_type] => utility [patent_app_number] => 16/330307 [patent_app_country] => US [patent_app_date] => 2017-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 84 [patent_no_of_words] => 45769 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12185487 [patent_doc_number] => 20180044423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR' [patent_app_type] => utility [patent_app_number] => 15/689163 [patent_app_country] => US [patent_app_date] => 2017-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 75 [patent_figures_cnt] => 75 [patent_no_of_words] => 115861 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15689163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12138566 [patent_doc_number] => 20180016647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'Bifidobacterium Longum' [patent_app_type] => utility [patent_app_number] => 15/683805 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25439 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15683805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17058955 [patent_doc_number] => 11103537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-31 [patent_title] => Cells expressing parathyroid hormone 1 receptor and uses thereof [patent_app_type] => utility [patent_app_number] => 15/683016 [patent_app_country] => US [patent_app_date] => 2017-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 21846 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15683016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12702190 [patent_doc_number] => 20180125896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-10 [patent_title] => Compositions and Methods for Treatment of Cardiovascular Disorders [patent_app_type] => utility [patent_app_number] => 15/681731 [patent_app_country] => US [patent_app_date] => 2017-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4990 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15117631 [patent_doc_number] => 20190345448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => PRODUCTION OF MEGAKARYOCTYE COMPOSITIONS AND THERAPIES FOR TREATMENT OF THROMBOCYTOPENIA [patent_app_type] => utility [patent_app_number] => 16/322584 [patent_app_country] => US [patent_app_date] => 2017-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12585006 [patent_doc_number] => 20180086831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => PROTEIN-BASED T-CELL RECEPTOR KNOCKDOWN [patent_app_type] => utility [patent_app_number] => 15/657981 [patent_app_country] => US [patent_app_date] => 2017-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12556 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15657981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12022296 [patent_doc_number] => 20170312394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'Compositions for Regenerating Defective or Absent Myocardium' [patent_app_type] => utility [patent_app_number] => 15/652895 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10331 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12794902 [patent_doc_number] => 20180156803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => P53 BIOMARKERS [patent_app_type] => utility [patent_app_number] => 15/651196 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33635 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13690011 [patent_doc_number] => 20170355960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-14 [patent_title] => IMMORTALIZED STEM CELL, COMPOSITIONS, PREPARATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/632831 [patent_app_country] => US [patent_app_date] => 2017-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15580 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19738507 [patent_doc_number] => 12215326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-04 [patent_title] => RNA-targeting system [patent_app_type] => utility [patent_app_number] => 15/632067 [patent_app_country] => US [patent_app_date] => 2017-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 60749 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18779125 [patent_doc_number] => 11820819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Chimeric antigen receptors (CARs), compositions and methods thereof [patent_app_type] => utility [patent_app_number] => 15/538620 [patent_app_country] => US [patent_app_date] => 2017-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 231 [patent_figures_cnt] => 257 [patent_no_of_words] => 83211 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 304 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18779125 [patent_doc_number] => 11820819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Chimeric antigen receptors (CARs), compositions and methods thereof [patent_app_type] => utility [patent_app_number] => 15/538620 [patent_app_country] => US [patent_app_date] => 2017-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 231 [patent_figures_cnt] => 257 [patent_no_of_words] => 83211 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 304 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538620 [rel_patent_id] =>[rel_patent_doc_number] =>)